Originally developed by Metabolic Pharmaceuticals in Australia, it was designed as a shorter, modified version of hGH to retain its fat-burning (lipolytic) properties
Made in USA
[2] [16] Dietary deficiency without neurological features: Initial loading doses followed by maintenance therapy, with consideration of oral supplementation in appropriate cases
Areas of active exploration include: Gastrointestinal healing (e.g., IBD, ulcers, leaky gut) Neurodegenerative conditions (e.g., Parkinsons, Alzheimers) Vascular repair (e.g., post-stroke recovery) PTSD and mood disorders Spinal cord injury repair With its unique ability to bridge multiple systemsfrom vascular to neural to connective tissueBPC-157 holds promise in areas far beyond orthopedic healing
The decrease in myocardial contractability and heart rate, as well as the reduction in blood pressure, produced by atenolol generally lead to a reduction in myocardial oxygen consumption which accounts for the effectiveness of the drug in chronic stable angina pectoris